Older males who were treated with androgen deprivation therapy for prostate cancer had an increased risk of developing Alzheimer's disease over a ten-year follow-up.
By inducing hot flashes, most commonly associated with menopause, in both male and female mice, researchers discover Kiss1 neurons initiate a fast boost in skin temperature followed by a drop in core body temperature.
Men with prostate cancer who are treated with testosterone lowering drugs are almost twice as likely to develop dementia within 5 years as those with the same cancer who are treated with different therapies, a new study reports.
A new study reports men who take testosterone reducing therapy for prostate cancer have an increased risk of developing Alzheimer's disease.
